Oropharyngeal Squamous Cell Carcinoma (OPSCC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 

Oropharyngeal cancer is a condition where cancerous cells develop in the tissues of the oropharynx, which constitutes the middle part of the pharynx. This area encompasses the tonsils, the back of the tongue, and the posterior throat walls. The pharynx serves as a passage for both air and food. Oropharyngeal cancers are commonly associated with HPV, and a positive HPV-16 polymerase chain reaction test of a biopsy or fine-needle aspiration is suggestive of oropharyngeal origin. Most oropharyngeal cancers are squamous cell carcinomas, thin, flat cells that line the interior of the oropharynx. Oropharyngeal cancer is relatively rare and typically afflicts individuals aged 50 to 80. The primary risk factors are smoking and excessive alcohol consumption. However, there has been a rise in cases among younger people infected with human papillomavirus (HPV). The signs and symptoms of oropharyngeal cancer can vary depending on the specific location, type, stage of cancer, and the individual genetic makeup of the tumor. These symptoms may include A lump in the neck or throat, Difficulty chewing or swallowing, along with pain, Sore throat, Unexplained ear pain, A persistent sore or ulcer lasting more than two weeks, Difficulty in mouth opening or tongue movement, A persistent white patch on the tongue or the lining of the mouth, Coughing up blood. Risk factors for oropharyngeal cancer can be attributed to environmental, behavioral, or genetic factors and include Tobacco use (cigarettes, pipes, cigars, chewing tobacco), Alcohol consumption, Exposure to human papillomavirus (HPV), including HPV type 16, A prior history of head and neck cancer.

  • The global incidence of oropharyngeal squamous cell carcinoma (OPSCC) is estimated to range from approximately 95,000 to 112,000 new cases each year. Over the last few decades, the incidence of OPSCC has been on the rise due to an increase in cases of human papillomavirus-positive (HPV+) OPSCC.

Thelansis’s “Oropharyngeal Squamous Cell Carcinoma (OPSCC) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Oropharyngeal Squamous Cell Carcinoma (OPSCC) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Oropharyngeal Squamous Cell Carcinoma (OPSCC) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Oropharyngeal Squamous Cell Carcinoma (OPSCC) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Oropharyngeal Squamous Cell Carcinoma (OPSCC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Metabolic Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Metabolic syndrome refers to a clustering of multiple disorders that collectively increase an individual's susceptibility to atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, as well as vascular and neurological complications such as cerebrovascular accidents. The underlying causes of metabolic syndrome typically include excess weight, obesity, a sedentary lifestyle, and genetic predisposition. This syndrome exerts detrimental effects on various body systems. Insulin resistance, a key component of metabolic syndrome, leads to microvascular damage, increasing the risk of endothelial dysfunction, vascular resistance, hypertension, and inflammation of vessel walls. Bariatric surgery is recognized as the most effective standalone therapy for metabolic syndrome. However, patients undergoing this procedure require long-term follow-up to mitigate potential surgical, nutritional, and psychiatric complications. Thelansis’s “Metabolic Syndrome Market Outl...
Read more

Type 1 Diabetes Mellitus (T1D) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Type 1 Diabetes Mellitus (T1D) is characterized as an autoimmune disorder resulting in the autoimmune destruction of insulin-producing pancreatic beta cells. This condition necessitates life-long insulin replacement, administered through multiple daily insulin injections, insulin pump therapy, or an automated insulin delivery system. The absence of insulin can lead to the development of Diabetic Ketoacidosis (DKA), a life-threatening condition. The most common symptoms associated with this disease are polyuria and polydipsia. Effective management of T1D involves: Multiple daily insulin injections Insulin pump therapy An automated insulin delivery system in conjunction with glucose monitoring Continuous Glucose Monitoring (CGM) is the preferred method. However, all individuals with T1D should be capable of performing Blood Glucose Monitoring (BGM) via capillary blood if CGM is not available. Acute complications of diabetes primarily include hypo...
Read more